. >> jack hodly is a health policy analyst at georgetown university's health institute. thanks for joining us tonight. glad to be there. ngs that jumped out at me as the president's announcement, increasedompetition in drug markets and provide new incentives for drug manufacturers to reduce list prices. what do you think of those? is that doable? >> it is doable, but i'm not t sut there's anything in this proposal that really gets us there. i ink theroposal is disappointing in the sense that it's a lot of ideas on the table, but n a lot of specifics that will have an effect in the short-term. >> if you wer to advise the president or the people who are going to be working on this package, because further negotiations are going to take place, is there one single thing that you think would be a game-changer, and would advise them to pursue? >> i mean, the potential game-changer would be for the government to have a more active role in looking at the prices of drugs directly, of negotiating, icularly on those drugs that are single-source drugs, where there ison really no com